"Did He Stop the Hair Loss Drug?"... Finasteride Missing from Trump's Medical Records

Took Hair Loss Medication for Years,
But Recently Omitted from Records
White House Explains: "Only Medications Deemed Necessary for Disclosure Included"

It has been revealed that the hair loss medication was omitted from U.S. President Donald Trump's recent medical records. The fact that he was taking this medication was first made public in 2017 by his then-personal physician, and it was reported that he continued the medication for several years afterward.

On June 4 (local time), the Wall Street Journal (WSJ) reported that "finasteride, the hair loss prevention drug that President Trump was known to have taken during his first term, has disappeared from his recently released medical records."

U.S. President Donald Trump. Photo by AP Yonhap News

Finasteride, also known by the brand name Propecia, is a medication taken by millions of people in the United States to prevent male pattern baldness. Three of President Trump's former personal physicians have stated that he took this medication both before taking office and throughout his first term as president.

However, in the health reports released after his reelection last year, finasteride was not mentioned. In the most recent health report released last month, three other medications were listed, but finasteride was not included.

The White House declined to answer questions about President Trump's past or current use of finasteride. In a statement, the White House said, "The current report only reflects medications that are deemed clinically appropriate to be released at this time," adding, "All health information relevant to the president's ability to perform his duties has been included."

Oldest President-Elect in U.S. History... "Health Information Should Be Public"

However, Robert Klitzman, a psychiatrist who leads the master's program in bioethics at Columbia University, pointed out that the White House's explanation raises further questions about the transparency of health information. Klitzman said, "It raises important questions about what else is not being disclosed," and emphasized, "Since some studies have linked finasteride to an increased risk of depression, it is important to disclose the president's health status and medication history."

Arthur Caplan, founder of the bioethics program at New York University School of Medicine, also said, "I do not trust the health reports released by the White House," asserting that "an independent medical evaluation is necessary."

President Trump, who will turn 80 on June 14, 2026, is the oldest person ever elected as president in U.S. history. Throughout his term, there have been ongoing speculations about his health, as bruises on the back of his hand and swelling in his legs were observed on several occasions.

President Trump's former personal physician claimed that the health statement released during the 2016 presidential campaign was essentially written under President Trump's direction. The White House was also criticized for not fully disclosing the severity of his illness during his COVID-19 infection in 2020. Trump did not release detailed health examination results during the 2024 presidential campaign either.

However, since March of last year, President Trump has visited Walter Reed National Military Medical Center three times, and his current personal physician, Sean Bababell, stated in the recently released health report that President Trump is "maintaining very good health."

Finasteride Use First Disclosed in 2017

When President Trump first ran for office, he did not disclose his use of finasteride. The health summary released in September 2016 also did not mention this medication.

Finasteride is generally considered a medication with few side effects and a high safety profile. Adam Friedman, chair of the Department of Dermatology at George Washington University School of Medicine, explained, "It helps slow ongoing hair loss and maintain existing hair."

This medication is also used for prostate cancer prevention and treatment. Taking finasteride can lower the level of prostate-specific antigen (PSA).

When President Trump's PSA level was found to be abnormally low in 2016, questions were raised within the medical community. Subsequently, his then-personal physician, Harold Bornstein, revealed in early 2017 that President Trump was taking finasteride for hair loss prevention.

Later, in a 2018 briefing, then-White House physician Ronny Jackson stated, "President Trump is taking 1 mg of Propecia daily to prevent male pattern baldness."

His successor, Sean Conley, also confirmed in June 2020 that President Trump was taking this medication.

Afterwards, the health reports released by the Trump campaign and the White House did not mention finasteride, but President Trump's PSA levels have continued to remain low.

However, Friedman explained that it is not possible to determine medication use based solely on PSA levels, nor is it appropriate to estimate use simply by observing changes in appearance. He added, "You cannot determine if someone is taking finasteride just by looking at their hair." He also noted that if the medication is discontinued, significant hair loss may occur.

This content was produced with the assistance of AI translation services.